登录

医疗保健服务提供商Ballad Health和Niswonger Foundation进行救生投资,以提高肾移植的可用性并降低护理成本

Ballad Health, Niswonger Foundation Make Lifesaving Investment to Enhance Availability of Kidneys for Transplant, Reduce Costs of Care

GlobeNewswire | 2024-05-09 | 翻译由动脉网AI生成,点击反馈

可切换为仅中文


JOHNSON CITY, Tenn., May 08, 2024 (GLOBE NEWSWIRE) -- More than 100,000 people are currently on the national transplant waiting list for a kidney. While waiting, most must rely upon expensive and invasive dialysis services to remain alive. Sadly, while so many people are waiting for a kidney for transplant, more than 8,500 kidneys donated in the United States each year never reach a recipient and are discarded.

田纳西州约翰逊市,2024年5月8日(环球通讯社)--目前有超过10万人在等待肾脏移植的国家名单上。在等待期间,大多数人必须依靠昂贵的侵入性透析服务才能存活。可悲的是,尽管如此多的人在等待肾脏移植,但美国每年捐赠的8500多个肾脏从未到达接受者手中,因此被丢弃。

On Saturday, April 20, a team of perfusionists from 34 Lives, a Ballad Ventures portfolio company, used a combination of 34 Lives technology and logistics to rescue a human kidney that had originally been deemed not usable for transplant. The rescued kidney was successfully transplanted into a recipient who had been on dialysis for almost two years and has now been successfully discharged from the hospital to home.

4月20日,星期六,来自Ballad Ventures投资组合公司34 Lifes的灌注师团队利用34 Lifes技术和物流相结合的方法,挽救了一个原本被认为无法用于移植的人类肾脏。获救的肾脏已成功移植到接受透析近两年的受者体内,目前已成功出院回家。

The transplant was performed at Indiana University Health by Dr. Bill Goggins, Professor of Surgery at Indiana University School of Medicine. Funded by a partnership that includes Johnson City, Tennessee-based Ballad Ventures, the venture capital subsidiary of Ballad Health; Greeneville, Tennessee-based Niswonger Foundation; and the National Kidney Foundation (NKF), 34 Lives uses innovative technology to rescue hard-to-place kidneys and state-of-the-art logistics to transport these fragile organs from donor to recipient.

印第安纳大学医学院外科教授比尔·戈金斯博士在印第安纳大学健康中心进行了移植手术。由包括位于田纳西州约翰逊市的Ballad Ventures在内的合伙企业资助,Ballad Ventures是Ballad Health的风险投资子公司;位于田纳西州格林维尔的尼斯旺格基金会;国家肾脏基金会(NKF)的34条生命使用创新技术拯救难以放置的肾脏,并使用最先进的物流将这些脆弱的器官从捐赠者运送到接受者。

34 Lives, a company formed at Purdue University, is conducting an Implementation Study throughout the United States that will document 80 rescued kidneys in collaboration with 10 Organ Procurement Organizations (OPOs) and four transplant hospitals: Indiana University Heath, Mt. Sinai (New York), University of Wisconsin and University of Miami/Jackson Memorial Hospital.

普渡大学成立的34 Lifes公司正在美国各地进行一项实施研究,该研究将与10个器官采购组织(OPO)和四家移植医院合作,记录80个获救的肾脏:印第安纳大学希思分校,西奈山(纽约),威斯康辛州大学和迈阿密大学/杰克逊纪念医院。

According to the NKF, nearly 750,000 Americans have irreversibl.

据NKF称,近75万美国人已经不可逆转。

推荐阅读

医疗保健服务提供商Ballad Health与Sevaro Health合作优化中风护理

HIT 2024-05-15 23:14

医疗保健服务提供商Ballad Health和Sevaro Health合作彻底改变中风护理

GlobeNewswire 2024-05-15 00:10

医疗保险提供商Anthem和综合性社区健康改善组织Ballad Health宣布新协议

businesswire 2024-04-22 21:30

GlobeNewswire

8168篇

最近内容 查看更多

Dyne Therapeutics将于美国东部时间明天5月20日上午8:00举办虚拟投资者活动,审查ACHIEVE和DELIVER试验的新临床数据

2 小时前

NASDAQ:NARI:Kessler Topaz Meltzer&Check,LLP通知投资者对Inari Medical,股份有限公司提起的证券集体诉讼

1 天前

Intercept提供了新数据,证明OCA-苯扎贝特联合治疗对2024年消化道疾病周治疗六个月后ALP和代谢结果的影响

1 天前

相关公司查看更多

Ballad Health

医疗保健服务提供商

立即沟通

产业链接查看更多